Mount Yale Investment Advisors, LLC Amgen Inc Transaction History
Mount Yale Investment Advisors, LLC
- $1.11 Billion
- Q1 2025
A detailed history of Mount Yale Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 744 shares of AMGN stock, worth $206,303. This represents 0.02% of its overall portfolio holdings.
Number of Shares
744
Previous 2,826
73.67%
Holding current value
$206,303
Previous $736,000
68.61%
% of portfolio
0.02%
Previous 0.06%
Shares
15 transactions
Others Institutions Holding AMGN
# of Institutions
3,214Shares Held
422MCall Options Held
7.05MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$14.6 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.16 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.04 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$3.66 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $148B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...